ASX - By Stock
|
A2M |
Re:
Media Updates
|
|
stanjupiter
|
8.4K |
4.6M |
4 |
15/04/21 |
15/04/21 |
ASX - By Stock
|
8.4K
|
4.6M
|
4
|
|
ASX - By Stock
|
A2M |
Re:
A2accumulate Mark06
|
|
stanjupiter
|
97 |
34K |
3 |
14/04/21 |
14/04/21 |
ASX - By Stock
|
97
|
34K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
455K |
54 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
1.0K
|
455K
|
54
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
455K |
76 |
09/04/21 |
09/04/21 |
ASX - By Stock
|
1.0K
|
455K
|
76
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
3.8K |
965K |
2 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
3.8K
|
965K
|
2
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
3.8K |
965K |
44 |
01/04/21 |
01/04/21 |
ASX - By Stock
|
3.8K
|
965K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment/Resignation
|
|
stanjupiter
|
136 |
32K |
55 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
136
|
32K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CHF Phase 3 Trial Results Presented at Investor Conference
|
|
stanjupiter
|
11 |
6.8K |
15 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
11
|
6.8K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stanjupiter
|
9.0K |
3.3M |
8 |
22/03/21 |
22/03/21 |
ASX - By Stock
|
9.0K
|
3.3M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Holders Only
|
|
stanjupiter
|
518 |
117K |
37 |
21/03/21 |
21/03/21 |
ASX - By Stock
|
518
|
117K
|
37
|
|
ASX - By Stock
|
A2M |
Re:
DON'T PANIC A2 HOLDERS, YOU ARE IN A BETTER SPOT THAN MOST
|
|
stanjupiter
|
406 |
110K |
7 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
406
|
110K
|
7
|
|
ASX - By Stock
|
A2M |
Re:
DON'T PANIC A2 HOLDERS, YOU ARE IN A BETTER SPOT THAN MOST
|
|
stanjupiter
|
406 |
110K |
18 |
19/03/21 |
19/03/21 |
ASX - By Stock
|
406
|
110K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
The investment case FOR Mesoblast
|
|
stanjupiter
|
324 |
79K |
83 |
18/03/21 |
18/03/21 |
ASX - By Stock
|
324
|
79K
|
83
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
stanjupiter
|
1.0K |
261K |
6 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
1.0K
|
261K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
stanjupiter
|
1.0K |
261K |
14 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
1.0K
|
261K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
stanjupiter
|
1.0K |
261K |
2 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
1.0K
|
261K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
stanjupiter
|
1.0K |
261K |
10 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
1.0K
|
261K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
stanjupiter
|
1.0K |
425K |
31 |
08/03/21 |
08/03/21 |
ASX - By Stock
|
1.0K
|
425K
|
31
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
stanjupiter
|
1.0K |
425K |
46 |
06/03/21 |
06/03/21 |
ASX - By Stock
|
1.0K
|
425K
|
46
|
|
ASX - By Stock
|
MSB |
Re:
MSB to dispute FDA finding in Type A meeting
|
|
stanjupiter
|
1.0K |
425K |
100 |
05/03/21 |
05/03/21 |
ASX - By Stock
|
1.0K
|
425K
|
100
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
stanjupiter
|
297 |
85K |
32 |
28/02/21 |
28/02/21 |
ASX - By Stock
|
297
|
85K
|
32
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
stanjupiter
|
272 |
117K |
19 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
117K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
stanjupiter
|
272 |
117K |
27 |
26/02/21 |
26/02/21 |
ASX - By Stock
|
272
|
117K
|
27
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
stanjupiter
|
1.0K |
261K |
64 |
25/02/21 |
25/02/21 |
ASX - By Stock
|
1.0K
|
261K
|
64
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
stanjupiter
|
175 |
35K |
17 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
175
|
35K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
stanjupiter
|
175 |
35K |
9 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
175
|
35K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
stanjupiter
|
175 |
35K |
9 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
175
|
35K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
stanjupiter
|
175 |
35K |
9 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
175
|
35K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
stanjupiter
|
175 |
35K |
17 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
175
|
35K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Self-Sustaining Commercialisation?
|
|
stanjupiter
|
175 |
35K |
55 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
175
|
35K
|
55
|
|
ASX - By Stock
|
MSB |
Re:
MSB Valuation
|
|
stanjupiter
|
179 |
38K |
11 |
16/02/21 |
16/02/21 |
ASX - By Stock
|
179
|
38K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
stanjupiter
|
1.0K |
261K |
12 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1.0K
|
261K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
stanjupiter
|
1.0K |
261K |
18 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1.0K
|
261K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
stanjupiter
|
1.0K |
261K |
27 |
14/02/21 |
14/02/21 |
ASX - By Stock
|
1.0K
|
261K
|
27
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
3.8K |
965K |
33 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
3.8K
|
965K
|
33
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
3.8K |
965K |
7 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
3.8K
|
965K
|
7
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
3.8K |
965K |
16 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
3.8K
|
965K
|
16
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
stanjupiter
|
3.8K |
965K |
8 |
13/02/21 |
13/02/21 |
ASX - By Stock
|
3.8K
|
965K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
stanjupiter
|
1.0K |
261K |
19 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.0K
|
261K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
455K |
11 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
1.0K
|
455K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
455K |
5 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
1.0K
|
455K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
455K |
21 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
1.0K
|
455K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
455K |
43 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1.0K
|
455K
|
43
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
455K |
29 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1.0K
|
455K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
stanjupiter
|
1.0K |
455K |
160 |
03/02/21 |
03/02/21 |
ASX - By Stock
|
1.0K
|
455K
|
160
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
stanjupiter
|
9.0K |
3.3M |
42 |
27/01/21 |
27/01/21 |
ASX - By Stock
|
9.0K
|
3.3M
|
42
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
stanjupiter
|
221 |
57K |
9 |
26/01/21 |
26/01/21 |
ASX - By Stock
|
221
|
57K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
stanjupiter
|
221 |
57K |
2 |
24/01/21 |
24/01/21 |
ASX - By Stock
|
221
|
57K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
stanjupiter
|
221 |
57K |
7 |
24/01/21 |
24/01/21 |
ASX - By Stock
|
221
|
57K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Seeking Alpha hatchet job
|
|
stanjupiter
|
221 |
57K |
11 |
23/01/21 |
23/01/21 |
ASX - By Stock
|
221
|
57K
|
11
|
|